<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="figure" id="F1" orientation="portrait" position="float">
 <label>Figure 1.</label>
 <caption>
  <p>Overview of infections and clinical events in patients treated with chimeric antigen receptor (CAR) T cells. Timeline depicts the periods of neutropenia, cytokine release syndrome, and bacterial, fungal, and viral infections for 53 study patients after CAR T-cell infusion (CTI) until allogeneic transplantation, death, or last follow-up date through day 180. Abbreviations: allo-HSCT, allogeneic hematopoietic stem cell transplantation; BSI, bloodstream infection; CDI, 
   <italic>Clostridium difficile</italic> infection; CRE, carbapenem-resistant Enterobacteriaceae; CTI, CAR T-cell infusion; 
   <italic>E. coli, Escherichia coli</italic>; ESBL, extended-spectrum Î²-lactamase; 
   <italic>G. sputi</italic>, 
   <italic>Gordonia sputi</italic>; HSV, herpes simplex virus; IPA, invasive pulmonary aspergillosis; 
   <italic>K. pneumoniae</italic>, 
   <italic>Klebsiella pneumoniae</italic>; MDR, multidrug-resistant; 
   <italic>P. aeruginosa</italic>, 
   <italic>Pseudomonas aeruginosa</italic>; PIV, parainfluenza virus; PNA, pneumonia; 
   <italic>S. maltophilia</italic>, 
   <italic>Stenotrophomonas maltophilia</italic>; URTI, upper respiratory tract infection; UTI, urinary tract infection; VRE, vancomycin-resistant 
   <italic>Enterococcus.</italic>
  </p>
 </caption>
 <graphic xlink:href="ciy15201" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
